Drug intelligence / Profile preview

iododeoxyuridine + methotrexate

Development stage
Preclinical
Lead developer
Pfizer
Modality
Small Molecules
Administration
Intravenous, Intra-arterial
01

Overview

This is a combination of two drugs, iododeoxyuridine and methotrexate. Iododeoxyuridine (IdUrd) is a halogenated pyrimidine analog that incorporates into DNA in place of thymidine, making DNA more susceptible to damage by ionizing radiation or radiolabeling. Methotrexate is an antimetabolite and antifolate agent that inhibits dihydrofolate reductase, leading to inhibition of DNA synthesis, repair, and cellular replication. The combination has been studied for synergistic effects in cancer therapy; thymidylate synthase inhibition by methotrexate can enhance the incorporation and cytotoxicity of iododeoxyuridine in tumor cells[8]. This approach aims to increase the therapeutic effect against rapidly dividing cancer cells while potentially allowing for more intense treatment regimens.

02

Targets

DHFR (Dihydrofolate reductase)

Beyond the preview

Go deeper on iododeoxyuridine + methotrexate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on iododeoxyuridine + methotrexate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call